The Golden Lounge

[Theo]

Pennies eh? You're so conservative...

I'm holding for Novartis to exercise the Phase 2b option sometime this Q. Only a $7 mil upfront & half the trials costs, but the commitment will entice even more investor speculation for the prospective milestone payments going forward:
"Novartis will pay 50% of Conatus’ Phase 2b emricasan development costs...can also obtain up to $15 million in an upfront payment in the form of convertible promissory notes from Novartis. If Novartis chooses to take the option that will trigger the ability for Conatus to earn up to $650 million in cash as certain milestones are met."